CTLA4 and non-small cell lung carcinoma: This case illustrates that isolated <i>PIK3CA</i>-mutant NSCLC can be highly refractory to conventional chemoimmunotherapy, including regimens incorporating a cytotoxic T-lymphocyte-associated antigen 4 inhibitor.